Literature DB >> 3275861

Two-week stimulation or blockade of the sympathetic nervous system in man: influence on body weight, body composition, and twenty four-hour energy expenditure.

K J Acheson1, E Ravussin, D A Schoeller, L Christin, L Bourquin, P Baertschi, E Danforth, E Jéquier.   

Abstract

Seven lean healthy young men were studied for 6 weeks during exposure to pharmacologic inhibition or stimulation of the sympathetic nervous system. For a period of 2 weeks their beta-adrenergic receptors were either blocked with propranolol hydrochloride (160 mg/d) or stimulated with terbutaline sulphate (15 mg/d). After a further 2 weeks of placebo administration (500 mg lactose/d), the subjects crossed over to the drug they had not been taking at the beginning of the experiment for another 14 days. During the last five days of each 2-week period, the subjects consumed a weight-maintaining diet, composed of 12% protein, 48% carbohydrate, and 40% fat. They consumed exactly the same menus on the same days during the subsequent study periods. Body weight and physical activity were measured every day for 6 weeks. Daily heart rate and nitrogen excretion were measured continuously for days at the end of each 2-week period, the last two days of which were spent in a respiration chamber where energy expenditure and a variety of metabolic parameters were measured. In the respiration chamber on the propranolol, placebo, and terbutaline treatments, respectively, significant differences were observed in mean daily heart rate (65 +/- 3, 75 +/- 4, and 84 +/- 4 beats/min), mean sleeping heart rate (51 +/- 2, 56 +/- 3, and 62 +/- 3 beats/min), nitrogen excretion (13.6 +/- 0.7, 12.6 +/- 0.6, and 11.9 +/- 0.6 g/d), fat oxidation (+1,045 +/- 95, +1,243 +/- 148, and +1,278 +/- 84 kcal/d) and thyroid hormones (12.0 +/- 0.7, 15.7 +/- 0.9, and 17.2 +/- 1.0 T3/T4 ratio).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3275861     DOI: 10.1016/0026-0495(88)90035-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  Plasma concentrations of free triiodothyronine predict weight change in euthyroid persons.

Authors:  Emilio Ortega; Nicola Pannacciulli; Clifton Bogardus; Jonathan Krakoff
Journal:  Am J Clin Nutr       Date:  2007-02       Impact factor: 7.045

2.  Chronic sympathetic attenuation and energy metabolism in autonomic failure.

Authors:  Cyndya Shibao; Maciej S Buchowski; Kong Y Chen; Chang Yu; Italo Biaggioni
Journal:  Hypertension       Date:  2012-04-02       Impact factor: 10.190

3.  Effects of terbutaline on basal thermogenesis of human skeletal muscle and Na-K pump after 1 week of oral use--a placebo controlled comparison with propranolol.

Authors:  B Fagher; H Liedholm; A Sjögren; M Monti
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

4.  Increase in stable isotope ratios driven by metabolic alterations in amphipods exposed to the beta-blocker propranolol.

Authors:  Caroline Ek; Andrius Garbaras; Zhenyang Yu; Hanna Oskarsson; Ann-Kristin Eriksson Wiklund; Linda Kumblad; Elena Gorokhova
Journal:  PLoS One       Date:  2019-05-16       Impact factor: 3.240

5.  Chronic treatment with terbutaline increases glucose and oleic acid oxidation and protein synthesis in cultured human myotubes.

Authors:  Christine Skagen; Tuula A Nyman; Xiao-Rong Peng; Gavin O'Mahony; Eili Tranheim Kase; Arild Chr Rustan; G Hege Thoresen
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-06-11

6.  Beta2 -agonist increases skeletal muscle interleukin 6 production and release in response to resistance exercise in men.

Authors:  Morten Hostrup; Jakob Grunnet Knudsen; Caroline Maag Kristensen; Søren Jessen; Henriette Pilegaard; Jens Bangsbo
Journal:  Scand J Med Sci Sports       Date:  2022-04-29       Impact factor: 4.645

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.